TSE:WEED Canopy Growth (WEED) Stock Forecast, Price & News C$0.98 -0.01 (-1.01%) (As of 06/7/2023 ET) Add Compare Share Share Today's RangeC$0.96▼C$1.0350-Day RangeC$0.98▼C$2.3852-Week RangeC$0.96▼C$6.44Volume2.70 million shsAverage Volume1.68 million shsMarket CapitalizationC$510.58 millionP/E RatioN/ADividend YieldN/APrice TargetC$4.03 ProfileProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesSocial MediaProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesSocial Media Canopy Growth MarketRank™ ForecastAnalyst RatingHold1.75 Rating ScoreUpside/Downside311.6% UpsideC$4.03 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.62 out of 5 stars 2.9 Analyst's Opinion Consensus RatingCanopy Growth has received a consensus rating of Hold. The company's average rating score is 1.75, and is based on 1 buy rating, 4 hold ratings, and 3 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$4.03, Canopy Growth has a forecasted upside of 311.6% from its current price of C$0.98.Amount of Analyst CoverageCanopy Growth has only been the subject of 1 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for WEED. Previous Next 0.0 Dividend Strength Dividend YieldCanopy Growth does not currently pay a dividend.Dividend GrowthCanopy Growth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for WEED. Previous Next 1.4 News and Social Media Coverage News SentimentCanopy Growth has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Canopy Growth this week, compared to 4 articles on an average week.Search InterestOnly 3 people have searched for WEED on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have not sold or bought any company stock.Percentage Held by Insiders33.53% of the stock of Canopy Growth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 14.21% of the stock of Canopy Growth is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Canopy Growth, their PEG ratio cannot be calculated.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Canopy Growth (TSE:WEED) StockCanopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.Read More Receive WEED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address WEED Stock News HeadlinesJune 7, 2023 | americanbankingnews.comCanopy Growth (TSE:WEED) Shares Down 4.4% June 5, 2023 | markets.businessinsider.comCannabis Giant Canopy Growth Removed From Market Benchmark S&P/TSX Composite IndexJune 8, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>June 2, 2023 | theglobeandmail.comCanopy Growth shrinks its way out of S&P/TSX Composite IndexJune 2, 2023 | markets.businessinsider.comBerger Montague (Canada) PC Announces Shareholder Investigation into Canopy Growth CorpMay 30, 2023 | ca.finance.yahoo.comCanopy Growth signs deal with Indiva for Wana brand of ediblesMay 30, 2023 | markets.businessinsider.comCanopy Growth Teams Up With Indiva To Grow WANA BrandsMay 30, 2023 | marketwatch.comCanopy Growth Takes 20% Stake in Indiva As Part of Wana Brand PactJune 8, 2023 | UNKNOWN (Ad)This NASDAQ Stock Is The Amazon Of Medical SupplyThis Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More NowMay 30, 2023 | finance.yahoo.comCANOPY GROWTH AND INDIVA ANNOUNCE AGREEMENT TO POSITION WANA GUMMIES FOR CONTINUED NORTH AMERICAN BRAND LEADERSHIPMay 29, 2023 | msn.comS&P Global Removes Ratings on Canopy Growth, As Requested by the Cannabis CompanyMay 29, 2023 | msn.comDon't Avoid All Canadian Cannabis ProducersMay 27, 2023 | markets.businessinsider.comBerger Montague (Canada) PC Announces Shareholder Investigation into Canopy Growth Corp.May 26, 2023 | finance.yahoo.comConstellation Brands, Inc.: Top Beer Brands and Innovation Drive Growth at Wide-Moat Constellation BrandsMay 26, 2023 | msn.comMotherhood Brought Her To Marijuana, Now She's In A C-Suite At A Global Weed BrandMay 26, 2023 | marketwatch.comCanopy Growth Applies for Cease Trade Order Against Certain Directors, OfficersMay 26, 2023 | finance.yahoo.comCanopy Growth Announces Voluntary Application for a Management Cease Trade OrderMay 25, 2023 | msn.comUnpaid cannabis taxes pile up at Canadian Licensed ProducersMay 25, 2023 | stockhouse.comShareholder Alert: Robbins LLP Informs Investors of Class Action Against Canopy Growth Corporation (CGC)May 25, 2023 | proactiveinvestors.comCanopy Growth unveils latest plan for Canopy USA to comply with Nasdaq rulesMay 25, 2023 | msn.comThe Most Likely Scenario for Aurora Cannabis Stock Doesn't Look GoodMay 24, 2023 | finance.yahoo.comDelivra Health Brands Enters into Licence Agreement with Canopy Growth to Manufacture and Distribute its Leading Infused Topical Brand LivRelief(TM)May 24, 2023 | marketwatch.comCanopy Growth’s stock pops after it reveals latest plan to enter U.S. cannabis marketMay 22, 2023 | marketwatch.comCanopy Growth Modifies Structure of U.S. BusinessMay 22, 2023 | msn.comCanopy Growth stock pops premarket after it revises proxy statement on move into US market to comply with Nasdaq listing rulesMay 21, 2023 | americanbankingnews.comCanopy Growth Corp (TSE:WEED) Receives Average Rating of "Reduce" from AnalystsMay 19, 2023 | americanbankingnews.comCanopy Growth (TSE:WEED) Sets New 1-Year Low at $1.38See More Headlines WEED Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolTSE:WEED CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone+1-613-5999600FaxN/AEmployees2,700Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$4.03 High Stock Price ForecastC$13.00 Low Stock Price ForecastC$1.75 Forecasted Upside/Downside+311.6%Consensus RatingHold Rating Score (0-4)1.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)C($7.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net IncomeC$-3,140,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-112.00% Return on Assets-6.79% Debt Debt-to-Equity Ratio91.98 Current Ratio1.73 Quick Ratio2.32 Sales & Book Value Annual SalesC$440.96 million Price / Sales1.16 Cash FlowC$0.60 per share Price / Cash Flow1.63 Book ValueC$2.88 per share Price / Book0.34Miscellaneous Outstanding Shares521,000,000Free FloatN/AMarket CapC$510.58 million OptionableNot Optionable Beta2.28 Key ExecutivesMr. Bruce A. Linton (Age 52)Co-Founder, Chairman & Co-CEO Mr. Mark Anthony Nicholas ZekulinPres & Co-CEOMr. Timothy Rob SaundersExec. OfficerMr. Rade KovacevicExec. VPMr. Mike LeeActing Chief Financial OfficerKey CompetitorsICC LabsCVE:ICCLeaf MobileTSE:LEAFOrganigramTSE:OGIKnight TherapeuticsTSE:GUDSupreme CannabisTSE:FIREView All CompetitorsInsidersDavid Angelo LazzaratoSold 3,733 sharesTotal: C$11,087.01 ($2.97/share)View All Insider Transactions WEED Stock - Frequently Asked Questions Should I buy or sell Canopy Growth stock right now? 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 3 sell ratings, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" WEED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WEED, but not buy additional shares or sell existing shares. View WEED analyst ratings or view top-rated stocks. What is Canopy Growth's stock price forecast for 2023? 8 brokers have issued 12-month price targets for Canopy Growth's shares. Their WEED share price forecasts range from C$1.75 to C$13.00. On average, they predict the company's stock price to reach C$4.03 in the next year. This suggests a possible upside of 311.6% from the stock's current price. View analysts price targets for WEED or view top-rated stocks among Wall Street analysts. How have WEED shares performed in 2023? Canopy Growth's stock was trading at C$3.14 on January 1st, 2023. Since then, WEED shares have decreased by 68.8% and is now trading at C$0.98. View the best growth stocks for 2023 here. What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include Aurora Cannabis (ACB), Aphria (APHA), Aurora Cannabis (ACB), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACBFF), GW Pharmaceuticals (GWPH) and Alibaba Group (BABA). What is Canopy Growth's stock symbol? Canopy Growth trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WEED." How do I buy shares of Canopy Growth? Shares of WEED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Canopy Growth's stock price today? One share of WEED stock can currently be purchased for approximately C$0.98. How much money does Canopy Growth make? Canopy Growth (TSE:WEED) has a market capitalization of C$510.58 million and generates C$440.96 million in revenue each year. The company earns C$-3,140,000,000.00 in net income (profit) each year or C($7.19) on an earnings per share basis. How many employees does Canopy Growth have? The company employs 2,700 workers across the globe. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 Hershey Dr, SMITHS FALLS, ON K7A 0A8, Canada. The official website for the company is www.canopygrowth.com. The company can be reached via phone at +1-613-5999600. This page (TSE:WEED) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.